Image Guided Systems Market: By Product (X-ray fluoroscopy, Endoscopy, Computed Tomography, MRI, PET, Ultrasound Systems, Others), By Application (Cardiology, Neurology, Urology, Others) Geography.  

Image Guided Systems Market size was estimated at USD 4.8 billion in 2022, growing at a CAGR of 6.2% from 2023-2029. Image guiding systems or interventional radiology is the minimally invasive procedure for diagnosis and treatment for some of the diseases,especially for vascular and non-vascular diseases. Industry trends in the market are evolving, which will aid players in developing successful long-term strategies. Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behavior and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The Image Guided Systems Market report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions. Geographically The Market is divided into five key regions, i.e. Europe, North America, Latin America, Asia- Pacific, and The Middle East & Africa. Many academic institutions are also funding cancer radiation experiments in order to improve the efficacy of treatment options. This will very certainly help to expand the market. One such programme is the Brigham and Women's Hospital's Image-guided Therapy Program, which aims to advance imaging and therapeutic technology in order to develop less invasive surgical and interventional methods.

Image Guided Systems Market Key Developments:

• In January 2017, 7D Surgical announced today that it has received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) and a medical device license from Health Canada enabling the North American commercial launch of its innovative Machine-vision Image Guided Surgery (MIGSâ„¢) system for spine surgery, the 7D Surgical System.